{"ticker": {"uuid": "9ec3a845-be74-4214-88bc-8d8f253ae85b", "symbol": "000963", "name": "Huadong Medicine Co., Ltd", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Huadong Med stock trades steady as earnings and pipeline shape outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdnFOaVItanduS0VST25DMmpTblF5ck1FNHVSOEtieVVGS3FFbHpndTZnYWhJOW9OWG5SS0NFMHdHSFUzWmFNLTVLSjRIajdtdjdqSlFZaUhoaUQxOHNGOXlBQTFzWGt5cF9iU0Ftc2NQb0xsS192NFBTQTZtYnBVMWdwa1k2RDhmSWdlVWx0LXBLNnFuQnRIWm1hUGx3QWRqcTBIXy1sZk5KN3BfM01ieTMtaktRTzREdGl2cDlDZy1BUFU2aW1maQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-16T16:35:00+00:00", "published_display": "16 Jul 2026 16:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Huadong gets China rights to Imbiologics\u2019 Oxtima program for \u20a9430B", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOeTJqT2RQaGJuR3E5MEtUbThybkQyUnlNYlQtSGtHMURXTUlDZjV0dFJSc214VmNBa1kwTDV2NUxCSjBfS1BJbDQ5Vkx5VWlLeEh0V2R6WEdjQXVvNlJlcTZwbGI2cXlTcVFyazk2bFVVb1V4OGpkcWVKU0xXeTZmd0N1N3Mzb1JYakk1dnZHSGJqZDRXdUpRSTNucGtUVV9fVGdyUVlRZWI?oc=5", "source_name": "BioWorld News", "published_at": "2024-08-27T07:00:00+00:00", "published_display": "27 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Huadong Med stock trades steady as earnings and pipeline shape outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdnFOaVItanduS0VST25DMmpTblF5ck1FNHVSOEtieVVGS3FFbHpndTZnYWhJOW9OWG5SS0NFMHdHSFUzWmFNLTVLSjRIajdtdjdqSlFZaUhoaUQxOHNGOXlBQTFzWGt5cF9iU0Ftc2NQb0xsS192NFBTQTZtYnBVMWdwa1k2RDhmSWdlVWx0LXBLNnFuQnRIWm1hUGx3QWRqcTBIXy1sZk5KN3BfM01ieTMtaktRTzREdGl2cDlDZy1BUFU2aW1maQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-16T16:35:00+00:00", "published_display": "16 Jul 2026 16:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Huadong gets China rights to Imbiologics\u2019 Oxtima program for \u20a9430B", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOeTJqT2RQaGJuR3E5MEtUbThybkQyUnlNYlQtSGtHMURXTUlDZjV0dFJSc214VmNBa1kwTDV2NUxCSjBfS1BJbDQ5Vkx5VWlLeEh0V2R6WEdjQXVvNlJlcTZwbGI2cXlTcVFyazk2bFVVb1V4OGpkcWVKU0xXeTZmd0N1N3Mzb1JYakk1dnZHSGJqZDRXdUpRSTNucGtUVV9fVGdyUVlRZWI?oc=5", "source_name": "BioWorld News", "published_at": "2024-08-27T07:00:00+00:00", "published_display": "27 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 46, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 58, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 30.1, "latest_week": "2026-07-17", "one_week_move": 2.5, "four_week_move": 6.2, "twelve_week_move": -12.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.038986, "market_dynamics_buy_signal": true, "relative_strength": -20.790707, "fair_value_gap": -15.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 40.0268, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.5% over one week, +6.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": ["Market Dynamics buy signal"], "opportunities": ["Market Dynamics is showing a buy signal in the latest weekly context."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad-hoc-news.de", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.5% over one week, +6.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Huadong Med stock trades steady as earnings and pipeline shape outlook"}], "updated_at": "2026-07-21T23:59:12.026109+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}